BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines - PubMed (original) (raw)
. 2000 Nov 1;60(21):6171-7.
F Shanahan, Y Chen, L Lian, P Ha, K Hendricks, S Ghaffari, D Iliev, B Penn, A M Woodland, R Smith, G Salada, A Carillo, K Laity, J Gupte, B Swedlund, S V Tavtigian, D H Teng, E Lees
Affiliations
- PMID: 11085541
BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines
A K Wong et al. Cancer Res. 2000.
Abstract
Human BRG1 is a component of the evolutionarily conserved SWI-SNF chromatin remodeling complex. BRG1 has been implicated in growth control through its interaction with the tumor suppressor pRb and may consequently serve as a negative regulator of proliferation. Postulating that BRG1 may itself be a tumor suppressor gene, we screened a panel of tumor cell lines to determine whether the gene is targeted for mutation. We report that the COOH-terminal region of BRG1 is homozygously deleted in two carcinoma cell lines, prostate TSU-Pr1 and lung A-427. In addition, biallelic inactivations of BRG1 were observed in four other cell lines derived from carcinomas of the breast, lung, pancreas, and prostate; their mutations in BRG1 included three frameshift lesions and one nonsense lesion. Point mutations were also discovered in a number of other cell lines, however in most cases any effect of these mutations on BRG1 function remains to be established. A variety of different mutations within BRG1, in several cell lines, suggest that BRG1 may be targeted for disruption in human tumors. Significantly, reintroduction of BRG1 into cells lacking BRG1 expression was sufficient to reverse their transformed phenotype inducing growth arrest and a flattened morphology. These data strongly support the model that BRG1 may function as a tumor suppressor and strengthen the hypothesis that the regulation of gene expression through chromatin remodeling is critical for cancer progression. It will be important to confirm these observations in primary tumors.
Similar articles
- Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP, Carretero J, Fraga MF, Esteller M, Sidransky D, Sanchez-Cespedes M. Medina PP, et al. Genes Chromosomes Cancer. 2004 Oct;41(2):170-7. doi: 10.1002/gcc.20068. Genes Chromosomes Cancer. 2004. PMID: 15287030 - Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser W Jr, Murchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE. Reisman DN, et al. Oncogene. 2002 Feb 14;21(8):1196-207. doi: 10.1038/sj.onc.1205188. Oncogene. 2002. PMID: 11850839 - The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
Glaros S, Cirrincione GM, Muchardt C, Kleer CG, Michael CW, Reisman D. Glaros S, et al. Oncogene. 2007 Oct 25;26(49):7058-66. doi: 10.1038/sj.onc.1210514. Epub 2007 Jun 4. Oncogene. 2007. PMID: 17546055 - BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.
Rodriguez-Nieto S, Sanchez-Cespedes M. Rodriguez-Nieto S, et al. Carcinogenesis. 2009 Apr;30(4):547-54. doi: 10.1093/carcin/bgp035. Epub 2009 Jan 28. Carcinogenesis. 2009. PMID: 19176640 Review. - When the SWI/SNF complex remodels...the cell cycle.
Muchardt C, Yaniv M. Muchardt C, et al. Oncogene. 2001 May 28;20(24):3067-75. doi: 10.1038/sj.onc.1204331. Oncogene. 2001. PMID: 11420722 Review.
Cited by
- BRG1 is a prognostic marker and potential therapeutic target in human breast cancer.
Bai J, Mei P, Zhang C, Chen F, Li C, Pan Z, Liu H, Zheng J. Bai J, et al. PLoS One. 2013;8(3):e59772. doi: 10.1371/journal.pone.0059772. Epub 2013 Mar 22. PLoS One. 2013. PMID: 23533649 Free PMC article. - Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence.
Burrows AE, Smogorzewska A, Elledge SJ. Burrows AE, et al. Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14280-5. doi: 10.1073/pnas.1009559107. Epub 2010 Jul 26. Proc Natl Acad Sci U S A. 2010. PMID: 20660729 Free PMC article. - SWItching on the transcriptional circuitry in melanoma.
Vinod Saladi S, Marathe H, de la Serna IL. Vinod Saladi S, et al. Epigenetics. 2010 Aug 16;5(6):469-75. doi: 10.4161/epi.5.6.12315. Epub 2010 Aug 16. Epigenetics. 2010. PMID: 20543574 Free PMC article. Review. - The SWI/SNF subunit BRG1 affects alternative splicing by changing RNA binding factor interactions with nascent RNA.
Gañez-Zapater A, Mackowiak SD, Guo Y, Tarbier M, Jordán-Pla A, Friedländer MR, Visa N, Östlund Farrants AK. Gañez-Zapater A, et al. Mol Genet Genomics. 2022 Mar;297(2):463-484. doi: 10.1007/s00438-022-01863-9. Epub 2022 Feb 20. Mol Genet Genomics. 2022. PMID: 35187582 Free PMC article. - Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
Lissanu Deribe Y, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J, Gao G, Mullinax RA, Khor T, Feng N, Lin YH, Wu CC, Reyes C, Peng Q, Robinson F, Inoue A, Kochat V, Liu CG, Asara JM, Moran C, Muller F, Wang J, Fang B, Papadimitrakopoulou V, Wistuba II, Rai K, Marszalek J, Futreal PA. Lissanu Deribe Y, et al. Nat Med. 2018 Jul;24(7):1047-1057. doi: 10.1038/s41591-018-0019-5. Epub 2018 Jun 11. Nat Med. 2018. PMID: 29892061 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous